Defiance Daily Target 2x Long LLY ETF
LLYX
Closed
$28.50
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
LLYX was created on 2024-08-07 by Defiance. The fund's investment portfolio concentrates primarily on health care equity. LLYX seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses.
Company
Defiance
Asset class
Equity
Inception date
2024
Investment segment
Health Care
ISIN
US88636J2612
Website
Key stats
Open
$28.53
Volume
265.50K
AUM
$73.45M
Prev. close
$28.32
Expense ratio
1.32%
P/E
0.00
$28.40
Day’s Range
$28.80
$14.55
52W Range
$29.95
What’s in the fund
2
Total sectors
Health Care
0.88%
Others
99.12%
Returns
Performance
_
Difference
_
Defiance Daily Target 2x Long LLY ETF
Dec
31
Dividends
The last payment date was Dec 31, 2025
Div. per Share
$0.70
Div. Yield
2.48%
Div. Growth YoY
-
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply